Clinical Trials Browser

Phase 4 × Unknown × flumatinib × Clear all

NCT04677439 2022-03-16

Flumatinib in CML-CP Patients With Ph+ Post Imatinib Failure

Phase 4 Unknown

Other hematologic neoplasm

Leukemia, Myeloid, Chronic-Phase